256 Newsroom — Uganda's Digital News Infrastructure
Business

China deaths reignite debate about using viruses to deliver CRISPR therapies - Endpoints News

Share
China deaths reignite debate about using viruses to deliver CRISPR therapies - Endpoints News
Image · Endpoints.news

What the report says

Two pediatric deaths in Chinese CRISPR trials reignite debate over AAV delivery risks, as many of the 15 genetic-medicine experts Endpoints spoke with point to high viral doses rather than gene editing itself.

Read the full report at Endpoints.news →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting